Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NaturaLife Asia is a South Korea-based health and wellness company focused on the development, marketing, export, and sale of herbal food supplements, multivitamins, probiotics, and sports nutrition products. Available sources describe the company as a private, active business serving Asian and global markets from Korea. Its product mix appears to be oriented toward consumer health and nutraceutical commercialization rather than innovative drug discovery or a clinical-stage biopharma pipeline. The company is also described in trade directories as operating alongside sister companies Weider Asia and Han Wha Pharma, suggesting links to a broader health-products and pharmaceutical manufacturing ecosystem. Overall, NaturaLife Asia looks most like a commercial nutraceutical and consumer-health company rather than a biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NaturaLife Asia.